Physician profile
Mark A George
NPI 1225031735
$4,519.43
in general payments reported to CMS, 2019-2025
11 companies · $479 in 2025
The $479 reported for 2025 was more than what 79% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,836 · 2020: $381 · 2021: $103 · 2022: $305 · 2023: $105 · 2024: $311 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $135 · Gift: $90.49 · Entertainment: $86.10 · Honoraria: $17.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.78 |
| Education | $135.00 |
| Gift | $90.49 |
| Entertainment | $86.10 |
| Honoraria | $17.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,907.24 | 2019-2025 | |
| Vatech America, INC. | $117.28 | 2022 | |
| Ultradent Products INC | $104.02 | 2022-2023 | Opalescence |
| Keystone Dental INC. | $103.69 | 2019-2024 | |
| Premier Dental Products Company | $68.47 | 2024-2025 | Aeropro Cordless Handpiece, Two Striper, Enamelon Gel |
| Colgate Oral Pharmaceuticals, INC. | $62.08 | 2024 | |
| Voco America INC. | $53.47 | 2022-2025 | Grandio So, Futurabond U, Structur Premium |
| Orapharma, A Division of Bausch Health US, LLC | $38.94 | 2022 | |
| Biohorizons Implant Systems INC. | $31.80 | 2020-2021 | |
| Zimvie INC. | $18.05 | 2024 | |
| Philips North America LLC | $14.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.